Butyrate producing microbiota are reduced in chronic kidney diseases

• Published in: Scientific reports Vol. 11; no. 1; p. 23530
• Main Authors: Gao, Bei, Jose, Adarsh, Alonzo-Palma, Norma, Malik, Taimur, Shankaranarayanan, Divya, Regunathan-Shenk, Renu, Raj, Dominic S.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 07.12.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 631/158/855; 631/326/2565/2134; Adolescent; Bacteria - genetics; Bacteria - metabolism; Butyrates - metabolism; Feces - microbiology; Female; Gastrointestinal Microbiome - genetics; Gastrointestinal Microbiome - physiology; Genera; Humanities and Social Sciences; Humans; Intestinal microflora; Kidney diseases; Kidneys; Male; Metagenomics; Metagenomics - methods; Microbiota; multidisciplinary; Public health; Renal Insufficiency, Chronic - microbiology; Science; Science (multidisciplinary); Severity of Illness Index
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-02865-0

Chronic kidney disease is a major public health concern that affects millions of people globally. Alterations in gut microbiota composition have been observed in patients with chronic kidney disease. Nevertheless, the correlation between the gut microbiota and disease severity has not been investigated. In this study, we performed shot-gun metagenomics sequencing and identified several taxonomic and functional signatures associated with disease severity in patients with chronic kidney disease. We noted that 19 microbial genera were significantly associated with the severity of chronic kidney disease. The butyrate-producing bacteria were reduced in patients with advanced stages of chronic kidney diseases. In addition, functional metagenomics showed that two-component systems, metabolic activity and regulation of co-factor were significantly associated with the disease severity. Our study provides valuable information for the development of microbiota-oriented therapeutic strategies for chronic kidney disease.